Presentation (CTI)

OBJECTIVES: An assessment is only as relevant as the outcomes it measures — and patients are often best placed to say which outcomes matter. This study examined how patient involvement and patient-relevant outcomes are incorporated into JCA scoping and assessment, and where the design could do more.
METHODS: A policy analysis used Regulation (EU) 2021/2282 (the scoping provisions under Article 8(6) and the Stakeholder Network under Article 29), implementing rules on the involvement of patients and experts, and literature on patient engagement and patient-relevant outcomes in HTA. The analysis considered the stages at which patients contribute and how their input shapes outcome selection.
RESULTS: The framework provides for patient and expert input at scoping and during assessment, and outcomes are intended to reflect Member States' needs rather than a fixed list. In practice, several constraints limit influence. Patient input is channelled through selection and confidentiality processes that can be demanding for smaller organisations; the weight given to patient-relevant outcomes relative to conventional clinical endpoints is not transparently specified; and the multiplication of subgroups and parameters can crowd out the outcomes patients value most, such as quality of life and functional status. Whether and how patient contributions changed an assessment is rarely visible in the published outputs, making engagement hard to evaluate.
CONCLUSIONS: Involvement should change outcomes, not just attendance lists. Clearer expectations for patient-relevant endpoints, accessible participation for smaller groups, and visible documentation of how patient input shaped scoping would make engagement meaningful.